StockData
GeoVax Labs, Inc. logo

GeoVax Labs, Inc. (GOVX) stock

GOVXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$1.99−0.02 (-1.00%)

Close on Nov 18, 2026Market cap $14.66MP/E –Yield –

GeoVax Labs operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

GeoVax Labs's operating income for the twelve months ending Jun 30, 2026 was -$20.53M. For fiscal 2025 it was -$21.64M. The highest annual figure on record is -$2.14M in fiscal 2012.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$21.64M–
FY2024Dec 31, 2024-$25.14M–
FY2023Dec 31, 2023-$26.74M–
FY2022Dec 31, 2022-$14.03M–
FY2021Dec 31, 2021-$18.75M–
FY2020Dec 31, 2020-$2.82M–
FY2019Dec 31, 2019-$2.37M–
FY2018Dec 31, 2018-$2.56M–
FY2017Dec 31, 2017-$2.17M–
FY2016Dec 31, 2016-$3.27M–
FY2015Dec 31, 2015-$2.69M–
FY2014Dec 31, 2014-$2.74M–
FY2013Dec 31, 2013-$2.29M–
FY2012Dec 31, 2012-$2.14M–
FY2011Dec 31, 2011-$2.35M–
FY2010Dec 31, 2010-$2.77M–
FY2009Dec 31, 2009-$3.32M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$4.44M–
Q1 FY2026Mar 31, 2026-$5.27M–
Q4 FY2025Dec 31, 2025-$4.44M–
Q3 FY2025Sep 30, 2025-$6.37M–
Q2 FY2025Jun 30, 2025-$5.42M–
Q1 FY2025Mar 31, 2025-$5.41M–
Q4 FY2024Dec 31, 2024-$8.34M–
Q3 FY2024Sep 30, 2024-$5.85M–
Q2 FY2024Jun 30, 2024-$5.06M–
Q1 FY2024Mar 31, 2024-$5.88M–
Q4 FY2023Dec 31, 2023-$7.69M–
Q3 FY2023Sep 30, 2023-$8.60M–
Q2 FY2023Jun 30, 2023-$6.18M–
Q1 FY2023Mar 31, 2023-$4.27M–
Q4 FY2022Dec 31, 2022-$5.39M–
Q3 FY2022Sep 30, 2022-$3.97M–
Q2 FY2022Jun 30, 2022-$2.24M–
Q1 FY2022Mar 31, 2022-$2.43M–
Q4 FY2021Dec 31, 2021-$13.74M–
Q3 FY2021Sep 30, 2021-$1.95M–
Q2 FY2021Jun 30, 2021-$1.49M–
Q1 FY2021Mar 31, 2021-$1.56M–
Q4 FY2020Dec 31, 2020-$1.34M–
Q3 FY2020Sep 30, 2020-$436.31K–
Q2 FY2020Jun 30, 2020-$448.11K–
Q1 FY2020Mar 31, 2020-$595.30K–
Q4 FY2019Dec 31, 2019-$591.07K–
Q3 FY2019Sep 30, 2019-$425.94K–
Q2 FY2019Jun 30, 2019-$653.94K–
Q1 FY2019Mar 31, 2019-$701.55K–
Q4 FY2018Dec 31, 2018-$634.33K–
Q3 FY2018Sep 30, 2018-$667.33K–
Q2 FY2018Jun 30, 2018-$638.13K–
Q1 FY2018Mar 31, 2018-$622.92K–
Q4 FY2017Dec 31, 2017-$517.22K–
Q3 FY2017Sep 30, 2017-$590.35K–
Q2 FY2017Jun 30, 2017-$518.15K–
Q1 FY2017Mar 31, 2017-$548.73K–
Q4 FY2016Dec 31, 2016-$935.80K–
Q3 FY2016Sep 30, 2016-$464.54K–

More GeoVax Labs figures

See a number that looks wrong?